← Leaderboards
Jason Heikenfeld
University Of Cincinnati
$1,215,064
Attributed
$1,215,064
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $408.1K · FY2022–25$500K$375K$250K$125K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,215,064 · 3
By mechanism
R21$1,215,064 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Cincinnati
Same institution · by research overlap
- Sean Patrick Collins$8,343,379
- Jeffrey Robbins$21,364,852
- James C Grotta$18,042,423
- Joseph Paul Broderick$95,619,410
- Zachary L Watkins$187,387
Others in their field
Other Rising Stars on “Technology”
- Gary Mays · Axle Informatics, Llc$59,170,713
- Richard Smith · Medical Device Innovation Consortium$41,401,350
- Jeffrey Leintz · National Opinion Research Center$39,962,545
- David Annett · Information Management Services, Inc.$34,721,865
- Julia Louise Moore Vogel · Scripps Research Institute, The$32,252,685
- Cyrus Wadia · Activate Global, Inc.$31,489,493
Research focus
TechnologyAptamerLettersDisease ManagementIntercellular FluidMolecularLongevityGlucose MonitorSensorDevicesSuccessMonitorDermalInsightGlucose SensorResistanceElectrodesContinuous Glucose MonitorBiosensorGlucoseDensityCardiacOxidation-ReductionMonolayer
Grant awards (6)
Answering an open and fundamentally important question: what skin-insertion depth is ideal for emerging continuous molecular monitors?$215,322
R21 · FY2025 · EB · contact PI
Aptamer tagging with redox quenchers: a critical breakthrough in the sensitivity of continuous electrochemical protein monitoring$189,642
R21 · FY2025 · EB · contact PI
Breakthrough Blocking-Layer Stability for Broader Clinical Utility of Continuous Aptamer Biosensors$232,290
R21 · FY2024 · EB · contact PI
Answering an open and fundamentally important question: what skin-insertion depth is ideal for emerging continuous molecular monitors?$175,803
R21 · FY2024 · EB · contact PI
Breakthrough Blocking-Layer Stability for Broader Clinical Utility of Continuous Aptamer Biosensors$247,790
R21 · FY2023 · EB · contact PI
Breakthrough Blocking-Layer Stability for Broader Clinical Utility of Continuous Aptamer Biosensors$154,217
R21 · FY2022 · EB · contact PI